human | Q5 |
P6178 | Dimensions author ID | 01045327606.64 |
P3835 | Mendeley person ID | reinaldo-martins3 |
P496 | ORCID iD | 0000-0002-0667-532X |
P3829 | Publons author ID | 2385482 |
P1053 | ResearcherID | I-3413-2015 |
P1153 | Scopus author ID | 15923219300 |
P108 | employer | Oswaldo Cruz Foundation | Q2474815 |
P734 | family name | Martins | Q1905655 |
Martins | Q1905655 | ||
Martins | Q1905655 | ||
P106 | occupation | researcher | Q1650915 |
P5008 | on focus list of Wikimedia project | WikiProject Zika Corpus | Q54439832 |
P21 | sex or gender | male | Q6581097 |
Q85340474 | Access to new technologies in multipatented vaccines: challenges for Brazil |
Q40206879 | Adverse events following yellow fever immunization: Report and analysis of 67 neurological cases in Brazil |
Q33613475 | Clinical and immunological insights on severe, adverse neurotropic and viscerotropic disease following 17D yellow fever vaccination |
Q40314920 | Cytokine signatures of innate and adaptive immunity in 17DD yellow fever vaccinated children and its association with the level of neutralizing antibody |
Q57178065 | HIV cure: global overview of bNAbs' patents and related scientific publications |
Q35210878 | Historical review of clinical vaccine studies at Oswaldo Cruz Institute and Oswaldo Cruz Foundation--technological development issues. |
Q34040600 | Immune response to the mumps component of the MMR vaccine in the routine of immunisation services in the Brazilian National Immunisation Program. |
Q56795571 | Immunogenicity, reactogenicity and consistency of production of a Brazilian combined vaccine against diphtheria, tetanus, pertussis and Haemophilus influenzae type b |
Q40432293 | Incidence of hypotonic-hyporesponsive episodes associated to the combined DTP/Hib vaccine used in Brazilian National Immunizations Program |
Q81510089 | Multicenter study on the immunogenicity and safety of two recombinant vaccines against hepatitis B |
Q59531994 | Multigenerational Brazilian family with malignant hyperthermia and a novel mutation in the RYR1 gene |
Q38100049 | Vaccine research, development, and innovation in Brazil: a translational science perspective |
Q82431491 | Yellow fever vaccination: some thoughts on how much is enough [Vaccine 23 (2005) 3908-3914] |
Q34523684 | Yellow fever vaccine supply: a possible solution |
Q29647477 | Zika puzzle in Brazil: peculiar conditions of viral introduction and dissemination - A Review |
Q56795583 | [Haemophilus influenzae type b infections and its prevention by vaccines] |
Q56795581 | [Missed opportunities for immunization] |
Q56795575 | [Technological development: a weak link in vaccine innovation in Brazil] |
Q56795578 | [Varicella: clinical aspects and prevention] |